Stockhub

Vicore Pharma Holding AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 09:0209:02, 16 August 2022 >Paris 1,056 bytes +1,056 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for a..."
Retrieved from "https://stockhub.co/research/Vicore_Pharma_Holding_AB"